The goal of this application is to conduct further analyses in the investigators' large, population-based case-control study. All subjects entered the study between 1987 and 1996. Alzheimer's disease (AD) cases were identified with new AD associated symptoms and then given a complete diagnostic evaluation by research clinical investigators. Control subjects were randomly selected from the same health maintenance organization (HMO) as cases. They were of similar age and sex, intact cognitive status, and were enrolled concurrently. All subjects have been followed annually to verify disease and vital status. The investigators state that the case subjects are likely to reflect sporadic AD occurrence in the general population. Subject accrual is complete; data and biological specimens have been obtained and stored; and the HMO computerized pharmacy database (est. 1977) contains medication history. Environmental and genetic factors may both play a role in the etiology of AD. Apolipoprotein E (e4-allele containing genotypes; APOE) has been shown to increase susceptibility to AD, i.e., it is a strong risk factor. The investigators will describe whether having an e4-containing genotype modifies the risk associated with occupational solvents, anti-inflammatory medications, estrogen replacement, and cigarette smoking. Polymorphic cytochrome p450 and glutathione-s-transferase (GST) genes biotransform environmental substances such as solvents and cigarette smoke. Depending on the polymorphic form of the gene, the original substance can be transformed to either a neutral or a risky state. The investigators will examine whether AD association with solvents or cigarette smoking is modified by polymorphic forms of CYP1A1, CYP2D6, CYP2E1, and GST-T1. Further, the alpha-1-antichymotrypsin gene (2-allele system) may act together with APOE to modify the APOE-AD association (Kamboh et al., 1995). The investigators will compare the strength of association between AD and APOE-e4 across alpha-1-antichymotrypsin genotypes (described as AA, AT, TT).

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project (R01)
Project #
Application #
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Anderson, Dallas
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Public Health & Prev Medicine
Schools of Public Health
United States
Zip Code
Wang, Li-San; Naj, Adam C; Graham, Robert R et al. (2015) Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA Neurol 72:209-16
Kim, Jong Hun; Song, Pamela; Lim, Hyunsun et al. (2014) Gene-based rare allele analysis identified a risk gene of Alzheimer's disease. PLoS One 9:e107983
Tsuang, Debby; Leverenz, James B; Lopez, Oscar L et al. (2012) GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology 79:1944-50
Ramos, Erin M; Lin, Ming-Tesh; Larson, Eric B et al. (2006) Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease. Arch Neurol 63:1165-9
Bowen, James D; Kamin, Richard; Leverenz, James B et al. (2005) Interrater reliability and accuracy in identifying ischemic strokes using computed tomography scans in people with dementia. J Am Geriatr Soc 53:1743-7
Edland, Steven D; Tobe, Vincent O; Rieder, Mark J et al. (2002) Mitochondrial genetic variants and Alzheimer disease: a case-control study of the T4336C and G5460A variants. Alzheimer Dis Assoc Disord 16:1-7
Kukull, W A (2001) The association between smoking and Alzheimer's disease: effects of study design and bias. Biol Psychiatry 49:194-9
Moceri, V M; Kukull, W A; Emanual, I et al. (2001) Using census data and birth certificates to reconstruct the early-life socioeconomic environment and the relation to the development of Alzheimer's disease. Epidemiology 12:383-9
McCormick, W C; Hardy, J; Kukull, W A et al. (2001) Healthcare utilization and costs in managed care patients with Alzheimer's disease during the last few years of life. J Am Geriatr Soc 49:1156-60
Moceri, V M; Kukull, W A; Emanuel, I et al. (2000) Early-life risk factors and the development of Alzheimer's disease. Neurology 54:415-20

Showing the most recent 10 out of 30 publications